Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary Hyperparathyroidism Due to Renal Causes”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Post-approval studies (Phase 4)Study completedNCT01939977
What this trial is testing

Efficacy and Safety of Paricalcitol in the Reduction of Secondary Hyperparathyroidism After Kidney Transplantation.

Who this might be right for
Secondary Hyperparathyroidism Due to Renal Causes
Fundación Senefro 148
Testing effectiveness (Phase 2)Ended earlyNCT03602261
What this trial is testing

Safety, Efficacy, PK and PD of CTAP101 (Calcifediol) ER Capsules for SHPT in HD Patients VDI

Who this might be right for
Secondary Hyperparathyroidism Due to Renal CausesChronic Kidney DiseasesVitamin D Deficiency+1 more
OPKO Health, Inc. 44
Not applicableStudy completedNCT04267965
What this trial is testing

Pulmonary Function, Voice and Swallowing Symptoms After Parathyroidectomy

Who this might be right for
Secondary Hyperparathyroidism Due to Renal Causes
Chang Gung Memorial Hospital 48
Not applicableNot Yet RecruitingNCT07151664
What this trial is testing

Retrospective Analysis of Quality of Life Changes in Patients Undergoing Parathyroidectomy for End-Stage Renal Disease

Who this might be right for
Secondary Hyperparathyroidism Due to Renal CausesEnd Stage Renal Failure
West China Hospital 60
Post-approval studies (Phase 4)Study completedNCT03588884
What this trial is testing

Repeated-dose Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of CTAP101, Immediate-release Calcifediol, High-dose Cholecalciferol, and Paricalcitol Plus Low-dose Cholecalciferol in Patients With Secondary Hyperparathyroidism, Chronic Kidney Disease 3-4 and Vitamin D Insufficiency

Who this might be right for
Secondary Hyperparathyroidism Due to Renal CausesVitamin D InsufficiencyCKD Stage 3+1 more
OPKO Health, Inc. 69
Not applicableUnknownNCT05549154
What this trial is testing

A Study on Prevention Strategies for CKD-SHPT and Related Complications Based on General Vitamin D Supplementation

Who this might be right for
Chronic Kidney Disease 5DSecondary Hyperparathyroidism Due to Renal CausesVitamin D Deficiency
First Affiliated Hospital Xi'an Jiaotong University 372